1 / 48

Pre-pregnancy Evaluation and Planning: Optimizing Outcome in High-Risk Women

Pre-pregnancy Evaluation and Planning: Optimizing Outcome in High-Risk Women. Siri L. Kjos, MD Harbor-UCLA Medical Center. Preconception Care: Basics. Use complete history and physical form. Preconception Care The Goal. What factors can be positively changed to improve perinatal outcome?

zahina
Download Presentation

Pre-pregnancy Evaluation and Planning: Optimizing Outcome in High-Risk Women

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pre-pregnancy Evaluation and Planning: Optimizing Outcome in High-Risk Women Siri L. Kjos, MD Harbor-UCLA Medical Center

  2. Preconception Care: Basics Use complete history and physical form

  3. Preconception CareThe Goal What factors can be positively changed to improve perinatal outcome? Maternal Neonatal

  4. Preconception CareGenetic Screening • Identification of inheritable disorders in family • Determine if patient and/or partner should be screened for carrier status • Genetic referral? • Ever-expanding molecular genetic testing • Counseling for identified disorders

  5. Preconception CareGenetic Screening • Common inheritable/genetic disorders • Tay-Sachs • Thalassemia • Sickle cell anemia • Cystic fibrosis • Mental retardation (Fragile x) • Muscular dystrophy, Huntington’s Chorea • Fetal erythroblastosis (Rh disease) • Chromosomal anomalies

  6. Preconception Care: Medications • Prescription • Daily and irregularly used medication • Treatment for chronic conditions • Pain killers, tranquilizers • Weight loss medication • Over-the counter • Alternative or herbal medicines

  7. FDA Classification for Teratogenicity

  8. Known Teratogens

  9. Known Teratogens

  10. Known Teratogens

  11. Preconception Care: Drugs • Alcohol • Pattern of use? • Questionnaires: CAGE, TACE, TWEAK • TERATOGENIC: Fetal alcohol syndrome (abnormal facies, mental retardation, IUGR, microcephaly) • Cigarette Smoking • Amount smoked • IUGR (25%), LBW, PTD, Sudden infant Death • STOP SMOKING! • Smoking cessation programs, nicotine patches • Illicit Drug use

  12. Preconception Care: Hepatitis B • Transmission • parenteral and sexual contact • Vertical: mother to newborn • Infected newborns (HbSAg+) • Complete resolution: 85-90% • Chronically infected: 10-15% • Of these 15-30% develop chronic active dz (persisent hepatitis, cirrhosis, hepatocellular carcinoma)

  13. Preconception Care: Hepatitis B • Maternal HbSAg+: • 10-20% vertical transmission • HBeAg+ and HbSAg +: 80-90% • Timing of maternal infection • 1st trimester: 10% transmission • 3rd trimester: 80-90% transmission • Passive + active immunization at birth • 85-90% protection • ACOG: recommend preconception testing • Immunize high-risk (recombinant DNA) MMW 1991: 40(r13):1-25 ACOG Technical Bulletin: July 1998: No 248

  14. Preconception Care: Immunization ACOG Committee Opinion: Dec 2000: No 246

  15. Preconception Care: HIV testing • Maternal Rx during pregnancy reduces vertical transmission • AZT prophylaxis: ↓ from 26% to 8% • Combination Rx: transmission rare • US Public Health, ACOG*, IOM: • Recommend Universal testing in pregnancy • Recommend offering all women testing as part of preconception care and counseling *ACOG Statement of Policy May 1999

  16. http://www.mypyramid.gov/downloads/MyPyramid_Anatomy.pdf

  17. http://www.mypyramid.gov/downloads/MiniPoster.pdf

  18. http://www.mypyramid.gov/downloads/worksheets/Worksheet_1800_18.pdfhttp://www.mypyramid.gov/downloads/worksheets/Worksheet_1800_18.pdf

  19. Recommended Weight Gain during Pregnancy based on Pre-pregnancy BMI Nutrition During Pregnancy: National Academy of Sciences, 1990

  20. Nutrition: Prescription of a Balanced Diet Committee on Diet and Health of the National Research Council, 1989

  21. Preconception Care: Exercise • Cardiovascular Fitness • Ability to maintain prolonged period of physical activity • Low intensity program: 30-60 minutes • 3-4 times per week • Goal: ↑aerobic capacity (VO2 max) • Measure HR: (220-age) x 60-80% = target HR • All exercise should be encouraged: • Walking, cycling, swimming, dance… ACOG Technical Bulletin No 173: Oct 1992

  22. 1996 NIH Recommendations for Exercise 50% of people do not exercise at all or sporadically Goal: EVERY DAY: • 30 minutes of moderate-intensity exercise • Yard work, brisk walking, cycling, swimming • Minutes may be accumulated as long as individuals maintained moderate exertion for no less than 10-15 minutes at a time • Get sedentary people into daily exercise • Those already exercising moderately: exercise more rigorously and more frequently

  23. Risk of NTD from Heat Exposure Study Population: 23,491 women at time of amniocentesis or MSAFP Adjusted for folate supplement, family history of NTD, maternal age & other heat source Milunsky, JAMA 1992, 268:882-6

  24. Folic Acid: Prevention of NTD Milunsky, JAMA 1989, 262:2847 n=22,591

  25. Recommendation for Folic Acid Supplementation in Reproductive-age Women • All women of childbearing age capable of becoming pregnant: • Should consume 0.4 mg/d of folic acid • Total consumption should be < 1.0 mg/d • High-risk women (with prior infant with NTD) should consult MD • General population risk of NTD: 1/1,000 MMWR 1992, Sept 11, 41 (R-14):1-7

  26. Folic Acid: Prevention of NTDMRC Vitamin Study Research Group Multi-center Double-blind Randomized Trial in Women with a History of Infant with Prior Neural Tube Defect Lancet 1991, 338:131

  27. Prevention of Recurrent NTD • General risk of recurrent NTD: 2-3%* • Recommend folic acid 4.0 mg/d • Prior to conception • Continue until the 12th week of pregnancy • Other high-risk groups: • Epilepsy on AED; Diabetes *Lancet 1991: 338:131

  28. Preconception Care: Folic Acid

  29. Preconception Care: Past Obstetrical History • History of prior fetal loss after documented cardiac motion • Thrombophilic disease (History of hypercoagulopathy) Anti-phospholipid syndrome • Anti-cardiolipin Ab (aCL) • Lupus anti-coagulant (LAC: aPTT, KCT (Exner), RVVT) Anti-thrombin III deficiences Activated Protein C Resistence Protein S & Protein C deficiencies • Incompetent cervix (painless loss, PTD) • Uterine anomaly • Coexisting medical disease • Prior cesarean deliveries: ↑risk of previa/accreta

  30. Preconception CareWomen with Medical Disease • Establish pregnancy risk • Complete medical evaluation/therapy • Diagnostic evaluation/ consultation • Surgery or procedures • Determine optimal medical control of preexisting disease • Titrate medicine to lowest dose, safest Rx • Effective contraception until • Completed health evaluation • Optimal health status

  31. Preconception care & DiabetesEuglycemic Control

  32. Preconception Care & Diabetes

  33. Preconception Care & Epilepsy

  34. Preconception Care & Cardiac Disease

  35. Preconception Care & Cardiac Disease

  36. Preconception Care & Mitral Valve Prolapse

  37. Preconception Care & Chronic Anticoagulation

  38. Preconception Care & Chronic Anticoagulation

  39. Preconception Care & Chronic Hypertension

  40. Preconception Care & Chronic Hypertension

  41. Preconception Care & Systemic Lupus Erythematous

  42. Preconception Care & Systemic Lupus Erythematous

  43. Preconception Care & Chronic Renal Failure

  44. Preconception Care & Renal Disease on Dialysis

  45. Preconception Care & Sickle Cell Disease

  46. Preconception Care & Sickle Cell Disease

  47. Preconception Care • Minimize the risk • Optimize maternal health • Use contraception until evaluation complete and health optimized • Stress the positive steps your patient can do to improve her outcome • Share control/responsibility for her health

More Related